Posted on December 1, 2021 by Sitemaster
In late October, we had commented on the then-latest revision of the National Comprehensive Cancer Network (NCCN)’s guidelines on the initial management of men with low-risk forms of localized prostate cancer. Specifically we had protested the removal of any suggestion that this form of prostate cancer should — preferably — be managed using active surveillance. The NCCN has now released a new revision to the guidelines that has modified the prior suggestion. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, guidelines, low-risk, NCCN, surveillance | 4 Comments »
Posted on October 20, 2021 by Sitemaster
As many readers will already be aware, the National Comprehensive Cancer Network (NCCN) has recently removed the word “preferred” from its statement regarding the use of active surveillance (AS) as an appropriate form of management of men with low-risk forms of localized prostate cancer. A broad swath of specialists in the initial management of low-risk disease, as well as many in the patient advocacy community, have been highly critical of this change to the NCCN guidelines. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: active, guidelines, low-risk, NCCN, surveillance | 10 Comments »
Posted on September 15, 2017 by Sitemaster
According to an article in the journal Cancer, men with low-risk prostate cancer diagnosed and managed at high-volume hospitals are 3.6 times more likely to be managed on active surveillance than those managed at low-volume institutions. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, application, guidelines, variation | 2 Comments »
Posted on January 2, 2017 by Sitemaster
The Society for Immunotherapy of Cancer has just issued a detailed statement on the role of immunotherapy in the management of prostate cancer. The full text of this article by McNeel et al. is available on line. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: guidelines, immunotherapy, Prostvac, Provenge, sipuleucel-T | 3 Comments »
Posted on May 16, 2016 by Sitemaster
Back in 2014, the American Cancer Society (ACS) issued a really rather thorough set of guidelines on the long-term management of survivors after initial treatment for prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: doctor, dysfunction, erectile, guidelines, primary care, survivorship | Leave a comment »
Posted on January 14, 2016 by Sitemaster
In its most recent update to its guidelines on the management of prostate cancer, the National Comprehensive Cancer Network (NCCN) has now stated that active surveillance is a first-line option for the management of favorable, intermediate-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, guidelines, surveillance | 7 Comments »
Posted on January 8, 2016 by Sitemaster
Posted on December 7, 2015 by Sitemaster
A new article just published in the journal Cancer concludes that “active surveillance is underused” in the management of low-risk prostate cancer. However, one has to be careful about how one interpret the data in (and the conclusions of) this particular article. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, guidelines, monitoring, practice, surveillance, waiting, watchful | Leave a comment »
Posted on August 12, 2015 by Sitemaster
In this month’s issue of the Journal of Urology, Dr. Peter Carroll (of UCSF) and Dr. Mark Dall’Era (formerly of UCSF and now at UCDavis) have contributed an editorial entitled “What is the optimal way to select candidates for active surveillance of prostate cancer?” … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active, expectant, guidelines, Management, patient, selection, surveillance | 1 Comment »
Posted on April 13, 2015 by Sitemaster
In June last year the American Cancer Society (ACS) published the first-ever set of long-term care guidelines for prostate cancer survivors. The “New” Prostate Cancer InfoLink addressed and discussed those guidelines at the time of their publication. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: guidelines, survivorship | Leave a comment »
Posted on December 16, 2014 by Sitemaster
A group of Australian experts has just released new draft guidance on prostate cancer screening and the role of expectant management (active surveillance and/or watchful waiting) in the management of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, guidelines, screening, surveillance, watchful waiting | 1 Comment »
Posted on April 1, 2013 by Sitemaster
According to a new article in the journal Nutrition and Cancer, “Consistent online dietary recommendations are lacking for patients during and after cancer treatment.” This will hardly come as a shock to many in the prostate cancer community, but an article like this one may help to initiate development of better guidelines. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: guidance, guidelines, nutrition | 3 Comments »
Posted on March 19, 2013 by Sitemaster
According to a report on the Medscape Oncology web site this morning, the National Comprehensive Cancer Network (NCCN) has just released, for the first time, guidelines for clinicians that address factors affecting “survivorship” after a diagnosis of and treatment for cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Uncategorized | Tagged: guidelines, NCCN, survivorship | Leave a comment »
Posted on January 10, 2013 by Sitemaster
As fodder for the ongoing discussion about the appropriateness of PSA testing (particularly of younger, healthy men) and risk for prostate cancer, we would draw our reader’s attention to an article from the Annals of Family Medicine just reprinted on the Medscape web site. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: guidelines, screening, testing | 2 Comments »
Posted on April 5, 2012 by Sitemaster
In an article just published in the Journal of Clinical Oncology, the American Society of Clinical Oncology (ASCO) has strongly recommended against the use of advanced imaging technologies for determining the spread of prostate cancer in men with early stage, low-risk disease. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: ASCO, Choosing Wisely, guidelines, outcome | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 